Brisbane-based bioscience company Microba has been recognised as one of the world’s top 25 science-based start-ups by Germany’s Falling Walls Foundation.

Microba provides clients with access to cutting-edge technology for gut microbiome analysis.

The accolade came at the Falling Walls conference in Berlin late last year, where Microba pitched its Metagenomic Analysis Platform (MAPTM) to more than 750 industry leaders, decision-makers and media representatives.

Microba CEO Blake Wills said it was an honour to pitch at the event, and to be named among the world’s best science start-ups.

‘Being invited to pitch at the event was certainly a highlight of what’s been a great year for us,’ Mr Wills said.

‘Being recognised as one of the world’s top 25 science start-ups is exceptionally pleasing.

‘It was an excellent opportunity to present to such a highly regarded group.’

Falling Walls is a German-based foundation that gives academics, entrepreneurs and other professionals an opportunity to present their research, business model, innovation or initiative to a distinguished audience from academia and business.

Last year was a big one for Microba, which is a world leader in high-resolution analysis of the gut microbiome.

In March, the company partnered with Korean-based Macrogen to develop new microbiome services in offshore markets and, in October, announced a partnership with US company Psomagen to deliver gut-analysis technology to the US market.

October also saw Microba winning the 2019 Lord Mayor’s Innovation Award and travelling to San Francisco to join the FAST accelerator program at the California Life Sciences Institute, coordinated by TIQ and Life Sciences Queensland.

‘While we’re continuing to make an impact in our global partnerships, Microba is also recognised as the key microbiome company in Australia,’ Mr Wills said.

‘We’ve helped more than 8,000 Australians understand more about their gut microbiome.’

Queensland Trade and Investment Commissioner for North America Viki Forrest said Microba’s recognition at Falling Walls was well deserved.

‘We’ve worked with Microba for a number of years and their innovations are globally significant,’ she said.

‘We supported their entry to the FAST program to help them enter the US market, and we’re already seeing that starting to bear fruit.

‘I’m sure we’ll be hearing a lot more about this Queensland company.’

In January, Microba representatives will return to San Francisco with other Queensland participants to complete the final stage of the FAST program.

They will also attend the BIO International Convention in San Diego in June.

Microba was not the only successful Queenslander at the Berlin Falling Walls event, with University of Queensland researcher Rhys Pirie taking out the top prize of Young Innovator of the Year.

The life sciences sector is identified as one of Queensland’s emerging export strengths in the Queensland Trade and Investment Strategy 2017–2022.